Homeopathic Management of breast tumor - An evidence based study

Homeopathic Management of benign neoplastic lesions of breast - An evidence based study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/06/004691

Enrollment

100

Registered

2014-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Benign Neoplastic Lesions Of the Breast

Interventions

Intervention1: Indicated Homeopathic Medicines, mentioned in Materia Medica: Arsenicum Album,calcarea Carb,Natrum Mur.,Lycopodium,Pulsatilla,Sepia,Silicea,carcinocin,sulphur,tuberculinum,thuja occi, a

Eligibility

Inclusion criteria

Inclusion criteria: Benign Breast Neoplastic Lesions

Exclusion criteria

Exclusion criteria: Postmenopausal women Before Menarche breast carcinoma Inflammatory breast diseases patients on oral contraceptive or hormone therapy or other medication

Design outcomes

Primary

Measure	Time frame
Clinical and ultrasonographic evolution of benign breast lumpTimepoint: 3 years	—

Secondary

Measure	Time frame
clinical and ultrasonographic evolution of benign breast lumpTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDr Purnima Shukla

GHMS, MD. Honorary director and homeopathic consultant

srmrc_gkp@yahoo.co.in05512202928

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026